Expression of transforming growth factor-β receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment

Urological Research

Volumn 25, Issue 2, 1997, Pages 103-111

  Wikstrom P ^a   Bergh, A ^a   Damber, J E ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Competitive polymerase chain reaction; Immunohistochemistry; Prostate cancer; TGF receptors

Indexed keywords

ESTROGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; ESTROGEN THERAPY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; ANDROGENS; ANIMALS; APOPTOSIS; BASE SEQUENCE; DNA PRIMERS; ESTRADIOL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; ORCHIECTOMY; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED F344; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0030895842     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01037924     Document Type: Article

References (49)

1. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK (1988) Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48:3898
2. Bassing CH, Howe DJ, Segarini PR, Donahoe PK, Wang X-F (1994) A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J Biol Chem 269:14861
3. Celi FS, Zenilman ME, Shuldiner AR (1993) A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res 21:1047
4. Chen RH, Moses HL, Maruoka EM, Derynck R, Kawabata M (1995) Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. J Biol Chem 270:12235
5. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156
6. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG (1988) p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261
7. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47.707
8. English HF, Kyprianou N, Isaacs JT (1989) Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15:233
9. Filmus J, Zhao J, Buick RN (1992) Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor β-1 (TGF-β1) and alters the number and type of TGF-β1 receptors in rat intestinal epithelial cell clones. Oncogene 7.521
10. Franze'n P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H. Miyazono K (1993) Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75:681
11. Garrigue-Antar L, Munos-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M (1995) Missense mutation of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55:3982
12. Geiser AG, Burmester JK, Webbink R, Roberts AB, Sporn MB (1992) Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J Biol Chem 267:2588
13. Haendler B. Hofer B (1990) Characterization of the human cyclophilin gene and of related processed pseudogenes. Eur J Biochem 1990:477
14. Ilio KY, Sensibar JA. Lee C (1995) Effect of TGF-β1, TGF-α and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J Androl 16:482
15. Ito M, Yasui W, Nakayama H, Yokozaki H, Ito H, Tahara E (1992) Reduced levels of transforming growth factor-β type I receptor in human gastric cancer. Jpn J Cancer Res 83:86
16. Kalkhoven E, Roelen BAJ, de Winter JP, Mummery CL, van den Eijnden-van Raaij AJM, van der Saag PT, van der Burg B (1995) Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6:1151
17. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, Lee C (1996) Stromal cells of the human prostate: initial isolation and characterization. Prostate 28:89
18. Kim IY, Ahn H-J, Zelner DJ, Park L, Sensibar JA, Lee C (1996) Expression and localization of transforming growth factor-β receptors type I and type II in the rat ventral prostate during regression. Mol Endocrinol 10:107
19. Kimchi A, Wang XF, Weinberg RA, Cheifetz S, Massague J (1988) Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 240:196
20. Kyprianou N, Isaacs JT (1988) Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123:2124
21. Kyprianou N, Isaacs JT (1989) Expression of transforming growth factor-β in the rat ventral prostate during castration induced programmed cell death. Mol Endocrinol 3.1515
22. Kyprianou N, English HF, Issacs JT (1990) Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748
23. Landström M, Bergh A, Tomic R, Damber J-E (1990) Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma. Prostate 17 57
24. Landström M, Damber J-E, Berg A, Tomic R (1992) Dose/response study of the effects of oestrogens on tumor growth and morphology in Dunning R3327 prostatic adenocarcinoma. J Cancer Res Clin Oncol 118:30
25. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775
26. Lindström P, Bergh A, Holm I. Damber J-E (1996) Expression of TGF-β1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment. Prostate (in press)
27. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague' J (1991) Structure and expression of the membrane proteoglycan betaglycan. a component of the TGF-β receptor system. Cell 54:659
28. Markowitz S, Wang J, Myeroff L, Parsosns R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M. Willson JKW (1995) Inactivation of the type II TGF-β1 receptor in colon cancer cells with microsatellite instability. Science 268-1336
29. Martikainen P, Kyprianou N, Issacs JT (1990) Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 127:2963
30. Massague J (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6:597
31. McKeehan WL, Adams PS (1988) Heparin-binding growth factor/ prostatatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type β. In Vitro Cell Dev Biol 24:243
32. Mulder KM, Segarini PR, Morris SL, Ziman JM, Choi HG (1993) Role of receptor complexes in resistance or sensitivity to growth inhibition by TGFβ in intestinal epithelial cell clones. J Cell Physiol 154:162
33. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts A, Sporn MB (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci U S A 91:8772
34. Steiner MS, Barrack ER (1990) Expression of transforming growth factors (TGFα and TGFβ) and epidermal growth factor (EGF) in normal and malignant rat prostate J Urol 143:240A
35. Steiner MS, Barrack ER (1992) Transforming growth factor-β1 overproduction in prostate cancer: effects of growth in vivo and in vitro. Mol Endocrinol 6.15
36. Steiner MS, Zhou Z-Z, Tonb DC, Barrack ER (1994) Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 13:2240
37. Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang X-F, Brattain MG (1994) Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269:26449
38. Taylor CR, Shi S-R, Chaiwun B, Young L, Imam SR, Cote RJ (1994) Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum Pathol 25:263
39. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH (1992) Transforming growth factor β1 as a biomarker for prostate cancer. J Cell Biochem 16H:54
40. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC (1993) Association of transforming growth factor β1 with prostate cancer: an immunohistochemical study. Hum Pathol 24.4
41. Tsuchida K, Lewis KA, Mathews LS, Vale WW (1993) Molecular characterization of rat transforming growth factor-β type II receptor. Biochem Biophys Res Commun 191:790
42. Wang J, Sun LZ, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKW, Brattain MG (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270:22044
43. Wang X-F, Lin HY, NG-Eaton E, Downward J, Lodish HF, Weinberg RA (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell 67:797
44. Weis-Garcia F, Massague J (1996) Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J 15:276
45. Verhagen APM, Aalders TW, Ramaekers FCS, Debruyne FMJ, Schalken JA (1988) Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 13:25
46. Westin P, Brändström A, Damber J-E, Bergh A (1995) Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Br J Cancer 72:140
47. Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E (1989) Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79
48. Yamashita H, ten Dijke P, Franzén P, Miyazono K, Heldin C-A (1994) Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269:20172
49. Zhao J, Buick RN (1993) Relationship of levels and kinetics of H-ras expression to transformed phenotype and loss of TGF-β1-mediated growth regulation in intestinal epithelial cells. Exp Cell Res 204:82